Armstrong Becomes Center of New Case by U.S. Anti-Doping Agency

Lance Armstrong faces accusations from the U.S. Anti-Doping Agency four months after federal prosecutors dropped a criminal drug probe against the seven-time Tour de France cycling champion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.